1. Home
  2. CDIO vs ASNS Comparison

CDIO vs ASNS Comparison

Compare CDIO & ASNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • ASNS
  • Stock Information
  • Founded
  • CDIO 2017
  • ASNS 1998
  • Country
  • CDIO United States
  • ASNS United States
  • Employees
  • CDIO N/A
  • ASNS N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • ASNS Telecommunications Equipment
  • Sector
  • CDIO Health Care
  • ASNS Telecommunications
  • Exchange
  • CDIO Nasdaq
  • ASNS Nasdaq
  • Market Cap
  • CDIO 6.4M
  • ASNS 6.7M
  • IPO Year
  • CDIO N/A
  • ASNS 2022
  • Fundamental
  • Price
  • CDIO $3.76
  • ASNS $0.43
  • Analyst Decision
  • CDIO
  • ASNS Strong Buy
  • Analyst Count
  • CDIO 0
  • ASNS 1
  • Target Price
  • CDIO N/A
  • ASNS $5.00
  • AVG Volume (30 Days)
  • CDIO 29.6K
  • ASNS 8.6M
  • Earning Date
  • CDIO 08-14-2025
  • ASNS 08-14-2025
  • Dividend Yield
  • CDIO N/A
  • ASNS N/A
  • EPS Growth
  • CDIO N/A
  • ASNS N/A
  • EPS
  • CDIO N/A
  • ASNS N/A
  • Revenue
  • CDIO $19,507.00
  • ASNS $5,265,000.00
  • Revenue This Year
  • CDIO $1,434.82
  • ASNS N/A
  • Revenue Next Year
  • CDIO $4,661.91
  • ASNS $104.77
  • P/E Ratio
  • CDIO N/A
  • ASNS N/A
  • Revenue Growth
  • CDIO N/A
  • ASNS N/A
  • 52 Week Low
  • CDIO $3.22
  • ASNS $0.34
  • 52 Week High
  • CDIO $53.10
  • ASNS $1.83
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 47.81
  • ASNS 43.67
  • Support Level
  • CDIO $3.62
  • ASNS $0.34
  • Resistance Level
  • CDIO $3.99
  • ASNS $0.48
  • Average True Range (ATR)
  • CDIO 0.27
  • ASNS 0.06
  • MACD
  • CDIO 0.03
  • ASNS -0.00
  • Stochastic Oscillator
  • CDIO 68.00
  • ASNS 32.72

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.

Share on Social Networks: